Healthcare Diagnostics Analyst Brackmann discusses pre-Q1 earnings (relevant companies: ABT BDSX CDNA DGX GH HOLX NEO OWLT QGEN TEM) on an Analyst/Industry conference call to be held on April 13 at 10:30 am. Webcast Link
Claim 55% Off TipRanks
Trade TEM with leveragePublished first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABT:
- Abbott Laboratories: Solid Q1 Setup and Resilient MedTech/Diagnostics Support Path to 2026 Targets Amid Manageable Geopolitical Headwinds
- Abbott price target raised to $144 from $142 at Barclays
- Abbott price target lowered to $134 from $138 at Evercore ISI
- Abbott price target lowered to $131 from $140 at BTIG
- Abbott integrates Precision Oncology portfolio into Flatiron’s OncoEMR